Once inside the tumor, myeloid cells undergo polarization toward TIM phenotype and release additional MCP-1, which forms an amplification loop helping to maintain a significant number of TIM in the tumor environment and reprogramming the tumor microenvironment into an immunosuppressive state [49,50]. The gene discussed is CCL2; the disease is neoplasm.